Altasciences at ACT 2026
Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website
Altasciences takes part in 6 sessions at ACT 2026 in San Antonio, and exhibits at Booth 304. Its program centres on nonhuman primate and miniature swine models, including background data and reference ranges for study animals. It also covers how the toxicity of lipid nanoparticle oligonucleotide drugs differs between rodents and monkeys, and brain-related safety testing for gene therapies.
| Organization | ACT 2026 Attendance |
|---|---|
Altasciences Laval, QC, Canada | ◆Diamond Supporter |
Drug development organization combining nonclinical studies, bioanalysis, early clinical trials, formulation and manufacturing for early-phase programs. | Booth Exhibiting at Booth 304 Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm Talk Sun Nov 15 12:00pm–12:55pm Poster Mon Nov 16 5:00pm–6:30pm Poster Mon Nov 16 5:00pm–6:30pm Poster Mon Nov 16 5:00pm–6:30pm Poster Mon Nov 16 5:00pm–6:30pm Talk Tue Nov 17 11:15am–11:45am |
Instantly find 20 buyers from Altasciences
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction